We earn commissions; partners may appear first. Disclosure
Advertising disclosure — We earn a commission when you start treatment through some links on this site, at no extra cost to you. CoreAge Rx is a featured partner, and providers we work with may appear first. How we're funded.
Women's-health guide
Ozempic, Wegovy and Zepbound Side Effects in Women: What's Different and What's Normal
Nausea, hair shedding, period changes, gallstones, bone and muscle, mood, libido and "Ozempic face": what women report on GLP-1s and when to call.
On this page
Featured partner
Grade ACoreAge Rx
93/100Compounded semaglutide and tirzepatide on one account, at one posted price that does not rise with your dose — tirzepatide being the option many women with insulin resistance ask about.
Check availability- Semaglutide
- Starting at $79/mo
- Tirzepatide
- Starting at $129/mo
HealthRX
Grade BPublishes the initial charge and renewal for both compounded injections, with clinician review and overnight shipping included; the longer-plan supply tables need clarification because a twelve-month plan lists only 48 weeks of medication.
Visit HealthRXWomen get the same side effects as men on GLP-1 medicines, and several studies suggest they get stomach side effects more often. A few are specific to women: hair shedding is several times more common, birth-control pills can be less reliable on tirzepatide and Foundayo, periods can change, and the labels report more hip and pelvis fractures in women.
Are GLP-1 side effects worse for women?
For some side effects, the numbers say yes. The clearest examples are printed on the drug labels themselves:
- Hair loss: in the Zepbound weight-loss trials, 7.1% of women reported hair loss compared with 0.5% of men1. On Wegovy it was 4% of women and 0.9% of men2.
- Fractures: in the large Wegovy heart-outcomes trial, hip and pelvis fractures were reported in 1% of women on Wegovy compared with 0.2% on placebo2.
For nausea and other stomach effects the picture is less tidy. A review of sex differences in GLP-1 treatment found that in two diabetes trials comparing dulaglutide and liraglutide, more women than men reported side effects overall (86.5% vs 61.4% on dulaglutide) and stomach side effects in particular; an analysis of semaglutide found nausea and vomiting more frequent in women even at the same drug levels in the blood; and a Korean drug-safety database found women about twice as likely as men to report any side effect3. One likely reason is dose per body weight: women are smaller on average, so the same weekly dose means higher exposure.
Not every study agrees. A 2026 analysis of US and Japanese adverse-event reports for tirzepatide found men more likely to report stomach problems4. Voluntary report databases are a weaker kind of evidence than trials, but it is a reminder that "women have it worse" is a tendency, not a rule.
What side effects do women report most on GLP-1s?
Here is the short version, with the deep guide for each.
| Side effect | How common (label or trial) | What helps | Deep guide |
|---|---|---|---|
| Nausea | 44% on Wegovy vs 16% placebo; 25% to 29% on Zepbound vs 8%21 | Slower dose increases, smaller meals, stop eating when full | This page, below |
| Constipation | 24% on Wegovy vs 11%; 11% to 17% on Zepbound vs 5%21 | Fluids, fiber, movement; ask about a stool softener | This page, below |
| Hair shedding | 4% of women on Wegovy; 7.1% of women on Zepbound21 | Protein, a slower rate of loss, checking iron and thyroid | Hair loss guide |
| Gallstones | 1.6% on Wegovy injection vs 0.7% placebo2 | Avoiding very fast loss; knowing the warning signs | Gallstones guide |
| Muscle loss | Part of all fast weight loss | Protein and strength training | Muscle loss guide |
| Bone and fractures | Hip/pelvis fractures 1% of women on Wegovy vs 0.2%2 | Strength training, calcium and vitamin D, bone checks after menopause | Bone density guide |
| Period changes | Common anecdotally; cycles often get more regular with PCOS | Tracking your cycle; contraception | Cycle guide |
| Less reliable birth-control pills | Tirzepatide and Foundayo labels15 | Non-oral method or backup during each window | Birth control guide |
| Dizziness, low blood pressure | Hypotension 1.3% on Wegovy vs 0.4%2 | Fluids, rising slowly, reviewing blood pressure pills | This page, below |
Why do GLP-1s cause nausea and constipation?
These medicines slow how fast the stomach empties and act on appetite centers in the brain. That is part of how they work, and it is also why the stomach complains. In the pooled Wegovy trials, most stomach side effects were mild to moderate, came and went, and clustered around dose increases; only 4.3% of people stopped the drug because of them6. The same pattern held for tirzepatide, where most stomach effects happened during dose escalation7.
What usually helps:
- Go slowly. Staying on a dose longer before stepping up is reasonable if side effects are bad. The 2023 international PCOS guideline also recommends gradual dose escalation to reduce stomach effects8.
- Eat smaller, plainer meals and stop at the first sign of fullness. Large, fatty or late meals are the usual triggers.
- Drink steadily. Vomiting and diarrhea can dehydrate you, and the labels warn that dehydration can strain the kidneys21.
- Treat constipation early with fluids, fiber and movement, and ask your prescriber before using a laxative regularly.
Weight loss does not depend on feeling sick. In the Wegovy trials, people with and without stomach side effects lost similar amounts of weight6.
Will a GLP-1 change my period?
It can. Many women notice cycles becoming more regular as weight and insulin levels fall, especially with PCOS, where a meta-analysis of liraglutide trials found significantly more frequent periods9. Others report heavier, lighter or irregular bleeding for a few months. Rapid weight change of any kind can shift a cycle, so it is hard to separate the medicine from the weight loss.
The practical point: more regular periods can mean ovulation has returned. If you are not trying to conceive, sort out contraception. If you are, read our guide to GLP-1s, fertility and pregnancy before you stop. Bleeding after menopause, or bleeding that soaks through pads hourly, needs a call to your clinician whatever the cause.
Why do women lose hair on GLP-1s?
The shedding is usually telogen effluvium, a temporary shed that follows rapid weight loss by two to four months. Both labels tie hair loss to weight reduction12, and women are far more likely to report it. In midlife it can overlap with perimenopausal thinning, low iron or thyroid problems, which is why our hair loss guide walks through how to tell them apart. If you have a thyroid condition, see also our thyroid guide.
What about gallstones, muscle and bone?
These three share a root: fast weight loss.
Gallstones form more easily when weight drops quickly, and women start from a higher baseline risk. The Wegovy label adds that gallbladder problems were more common on the drug "even after accounting for the degree of weight loss"2. Know the signs: pain in the upper right abdomen, fever, yellowing skin or eyes, or pale stools2. Details are in our gallstones guide.
Muscle goes along with fat in any large weight loss. Protein at every meal and resistance training two to three times a week are the main defenses; our muscle loss guide has the numbers.
Bone matters most after menopause, when estrogen loss already thins it. The higher rate of hip and pelvis fractures in women on Wegovy in the heart-outcomes trial2 is a reason to keep up strength training and ask about a bone density scan if you are postmenopausal. See our bone density guide.
Can a GLP-1 affect mood, libido or body image?
Mood: earlier labels for Wegovy and Zepbound carried a warning about suicidal thoughts. That warning section was removed from both labels in February 202621. Still, any new low mood, anxiety or loss of interest in things you enjoy deserves a conversation with your clinician, not a wait-and-see.
Libido: the evidence is thin and mixed. A 2026 review in Menopause noted that weight loss generally improves women's sexual function, but GLP-1 medicines may also dampen desire through effects on reward pathways in the brain; it called the clinical evidence "limited" and urged clinicians to ask about sexual health before and during treatment10. If desire drops, say so; it can also reflect perimenopause, mood or relationship factors.
Food and body image: appetite suppression can feel like relief or like a trigger. If you have a history of restrictive eating, binge eating or bulimia, read our eating disorder history guide before starting.
What is "Ozempic face"?
"Ozempic face" is a popular term for the hollowed, older look some people notice after losing a lot of weight quickly. A 2025 systematic review of plastic surgery literature described it as volume loss that resembles advanced aging and found that online searches for "Ozempic face" rose alongside searches for fillers and plastic surgeons11. It is not a drug toxicity; it is what fast fat loss does to the face, and it can happen with any method. Slower loss, protecting muscle and good skin care help somewhat. Fillers and other procedures are options some women choose later, once weight is stable.
What other conditions change the side-effect picture?
A few situations deserve their own conversation before you start:
- Migraine or idiopathic intracranial hypertension (IIH): GLP-1s are being studied for IIH, and headaches are a listed side effect. See our migraine and IIH guide.
- Thyroid disease: a personal or family history of medullary thyroid cancer or MEN 2 rules these medicines out; ordinary hypothyroidism does not. See the thyroid guide.
- Breastfeeding: the tablets and injections are labeled differently. See GLP-1s and breastfeeding.
- Monitoring: which blood tests a program should run, and when, is in our labs and monitoring guide.
When should you call a clinician about a GLP-1 side effect?
Most side effects are uncomfortable rather than dangerous. These are the exceptions, drawn from the warnings on the Wegovy and Zepbound labels21:
| Symptom | Possible cause | What to do |
|---|---|---|
| Severe stomach pain that won't go away, sometimes spreading to the back | Pancreatitis | Stop the medicine and seek care the same day |
| Upper-right abdominal pain, fever, yellow skin or eyes, pale stools | Gallbladder disease | Call your clinician promptly |
| Vomiting or diarrhea so bad you can't keep fluids down | Dehydration, kidney strain | Call the same day |
| Fainting, or dizziness when you stand | Low blood pressure | Call, especially if you take blood pressure pills |
| Swelling of the face, lips or throat; trouble breathing | Serious allergic reaction | Emergency care |
| A lump in the neck, trouble swallowing, persistent hoarseness | Thyroid (label warning) | Book a visit |
| A positive pregnancy test | Pregnancy | Stop the medicine and call your OB-GYN |
| A planned surgery or sedation | Risk of aspiration under anesthesia | Tell your surgeon and anesthesiologist well ahead |
| New low mood or thoughts of self-harm | Mood change | Call your clinician; in a crisis, call or text 988 |
If bowel symptoms are the main problem, our GLP-1 constipation guide separates routine treatment questions from warning signs that need prompt assessment.
How do you choose a program that takes side effects seriously?
The difference between a good and a poor experience on a GLP-1 is often the follow-up: someone who answers when nausea is bad, slows a dose increase, checks labs and asks about your cycle and contraception. Our ranking of GLP-1 programs for women and our menopause board compare what each includes. We earn a commission when you start treatment through some links on this site, at no extra cost to you. CoreAge Rx is a featured partner, and providers we work with may appear first. For detail on follow-up, see our reviews of CoreAge Rx, Enhance MD and Eden.
Educational content, not medical advice. Talk to a licensed clinician before starting any treatment.
Frequently asked questions
Do women get more side effects on Ozempic or Wegovy?
Several studies suggest women report stomach side effects such as nausea and vomiting more often than men, possibly because women are smaller and get a higher dose per pound. Hair loss is clearly more common in women: 4% vs 0.9% on Wegovy and 7.1% vs 0.5% on Zepbound in the label data. Not every study agrees on stomach effects, so it is a tendency rather than a rule.
Does Ozempic affect your period?
It can. Many women, especially with PCOS, find cycles become more regular as weight and insulin levels fall, and others notice temporary changes in timing or flow. More regular periods can mean ovulation has returned, so think about contraception if you are not planning a pregnancy.
Does Zepbound or Ozempic lower libido?
The evidence is limited and mixed. Weight loss often improves sexual function, but a 2026 review raised the possibility that GLP-1 medicines dampen desire through brain reward pathways in some women. Mention any change to your clinician; perimenopause and mood can also play a part.
Is hair loss on a GLP-1 permanent?
Usually not. It is typically a temporary shed linked to rapid weight loss, starting a few months in and settling as weight loss slows. If thinning continues or follows a pattern, ask about iron, thyroid and hormonal causes.
When is a GLP-1 side effect an emergency?
Severe stomach pain that won't go away (especially spreading to the back), signs of a serious allergic reaction, fainting, or being unable to keep fluids down need prompt care. Upper-right abdominal pain with fever or yellowing skin can mean gallbladder disease and needs a call to your clinician.
References
- Eli Lilly and Company (2026). Zepbound (tirzepatide) prescribing information. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- Novo Nordisk (2026). Wegovy (semaglutide) injection and tablets prescribing information. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- Rentzeperi E, Pegiou S, Koufakis T, et al. (2022). Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care. Journal of Personalized Medicine. https://pubmed.ncbi.nlm.nih.gov/35330453/
- Yu Z, Qi Y, Gan Q, et al. (2026). Adverse events associated with tirzepatide: a focus on subgroup-specific differences. BMC Pharmacology and Toxicology. https://pubmed.ncbi.nlm.nih.gov/41742317/
- Eli Lilly and Company (2026). Foundayo (orforglipron) prescribing information. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62
- Wharton S, Calanna S, Davies M, et al. (2022). Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/34514682/
- Rubino DM, Pedersen SD, Connery L, et al. (2025). Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/39789843/
- Teede HJ, Tay CT, Laven JJE, et al. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. European Journal of Endocrinology. https://pubmed.ncbi.nlm.nih.gov/37580861/
- Lu YT, Chang PH, Chen HJ, et al. (2026). Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/41508932/
- Castaneda R, Sepulveda D, Hurtado Andrade MD, et al. (2026). Weight loss interventions and sexual function in midlife women: the emerging role of glucagon-like peptide-1 receptor agonists. Menopause. https://pubmed.ncbi.nlm.nih.gov/42517362/
- Daneshgaran G, Shauly O, Gould DJ (2025). "Ozempic Face" in Plastic Surgery: A Systematic Review of the Literature on GLP-1 Receptor Agonist Mediated Weight Loss and Analysis of Public Perceptions. Aesthetic Surgery Journal Open Forum. https://pubmed.ncbi.nlm.nih.gov/40626110/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Keep exploring
Does Ozempic Affect Your Period? GLP-1s, Your Cycle and Hormones
Period changes on Ozempic, Wegovy and Zepbound: why cycles often come back, what heavier or irregular bleeding may mean, the pill caution, and libido.
Read the guide →Does Ozempic Cause Muscle Loss? What Women Over 40 Should Know
Does Ozempic cause muscle loss? What the Zepbound and Wegovy-dose studies measured, why midlife adds to a decline already underway, and what helps.
Read the guide →Ozempic & Zepbound for PCOS: What the Evidence Shows
What the PCOS trials of liraglutide, semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound) show for weight, periods and ovulation, and what to ask first.
Read the guide →Ozempic and Zepbound Hair Loss in Women: What's Causing It and What Helps
Ozempic and Zepbound hair loss in women: label rates by sex, why the shedding happens, and how to tell it from perimenopause, PCOS and low ferritin.
Read the guide →TrumpRx, LillyDirect, NovoCare: What Brand GLP-1s Cost Without Insurance in 2026
Self-pay prices for Zepbound, Wegovy, Ozempic, Foundayo and the Wegovy pill by dose, read October 2026, and who qualifies for the $50 Medicare Bridge.
Read the guide →Compounded Semaglutide vs Ozempic: Same Drug? (2026)
Compounded semaglutide is not the same as Ozempic or Wegovy. What differs, what the FDA changed in 2025–26, brand vs compounded prices, and what women weigh.
Read the guide →